The treatment options that are currently available for management of metastatic, progressive
radioactive iodine (RAI)-refractory differentiated thyroid cancers (DTCs), and medullary …

Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid carcinoma originating from
follicular epithelial cells. No explicit consensus can be achieved to date due to sparse …

Radioiodine uptake (RAIU) test with iodine-123 (Na [123 I] I) or iodine-131 (Na [131 I] I)
enables accurate evaluation and quantification of iodine uptake and kinetics within thyroid …

Simple Summary Molecular imaging utilizes radionuclides or artificially modified molecules
to image particular targets or pathways which are important in the pathogenesis of a certain …

Objectives Chemokines have been suggested to play significant roles in the progression of
malignant cancers. This study aimed to identify the chemokines related to malignant …

AIM As a classic theranostic radiopharmaceutical, radioiodine (131 I) has been utilized in
the management of differentiated thyroid cancer (DTC) for more than 8 decades, and the …

In this review we have brought forward various nuclear imaging modalities used in the
diagnosis, staging, and management of thyroid cancer. Thyroid cancer is the most common …

Non-invasive medical imaging modalities has become a standard/unique tool for the
diagnosis and staging of numerous diseases. Molecular imaging plays an important role in …

Introduction: Negative radioiodine (131I) whole-body scan with elevated serum
thyroglobulin (Tg) level are found in 20% of patients with differentiated thyroid cancer (DTC) …

Thyroid nodule is the most common presentation of thyroid carcinoma. Considering the
indolent course of the disease, indeed, the papillary thyroid cancer (PTC) microcarcinoma …